Blood News and Research

RSS

Novel device can help treat type I diabetes mellitus

Type I Diabetes Mellitus, also called T1D, is an autoimmune disorder that results in an irreversible loss of insulin-producing beta-cells found in the pancreas.

2 Apr 2021

Study reveals molecular mechanisms involved in eliminating unwanted cells in the body

Researchers have uncovered molecular mechanisms involved in removing unwanted cells in the body.

29 Mar 2021

Key molecule determines the pathogenesis of lupus

A new research work, published in JCI, has discovered that the endoplasmic reticulum of a neutrophil becomes stressed in the autoimmune disorder lupus.

29 Mar 2021

Virus-cell interaction may explain the high infection rate of COVID-19 virus

Bioengineering scientists have now detected a formerly unknown interaction between the spike (or “S”) protein of SARS-CoV-2 and receptors in human cells.

From Lehigh University 29 Mar 2021

New genetic evidence points to novel therapies for “silent” stroke

According to a study, researchers have discovered new genetic clues in individuals who had experienced small but often apparently “silent” strokes.

26 Mar 2021

New technique can measure thousands of proteins in a few minutes

Researchers from Charité - Universitätsmedizin Berlin and the Francis Crick Institute have developed a mass spectrometry-based technique capable of measuring samples containing thousands of proteins within just a few minutes.

26 Mar 2021

Fish oil provides health benefits based on the genetic makeup

Fish oil supplements are a billion-dollar industry built on a foundation of purported, but not proven, health benefits. Now, new research from a team led by a University of Georgia scientist indicates that taking fish oil only provides health benefits if you have the right genetic makeup.

From University of Georgia 26 Mar 2021

New label-free immune profiling assay to assess rapidly changing host immune response

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research Group (IRG) at the Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have developed a new label-free immune profiling assay that profiles the rapidly changing host immune response in case of infection, in a departure from existing methods that focus on detecting the pathogens themselves, which can often be at low levels within a host.

26 Mar 2021

Researchers use mathematical modeling to explain CAR T-cell therapy dynamics

Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas.

26 Mar 2021

Scientists identify new biomarkers in the blood of patients with malignant melanoma

A team of researchers has studied the molecular profile of small “messenger” vesicles called exosomes, produced by cancer stem cells (CSCs), which play a key role in the process of carcinogenesis and metastasis in the blood of patients with malignant melanoma.

26 Mar 2021

Study shows how a subset of T cells is generated in melanoma survivors affected by vitiligo

A few patients suffering from melanoma are known to respond quite well to immunotherapy and experience significant and long-lasting tumor regression.

25 Mar 2021

Study shows SARS-CoV-2 antibodies wane at different rates

Researchers from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID), and the Agency for Science, Technology and Research (A*STAR) Infectious Diseases Labs have discovered that antibodies against SARS-CoV-2 decline at different speeds, and these antibodies last for only a few days in some people but remain for many years in other individuals.

24 Mar 2021

Gender difference accounts for major psychiatric disorders

According to an analysis of sex variations in the genetics of bipolar disorder, schizophrenia, and major depressive disorders.

24 Mar 2021

Stem cell therapy could help restore debilitating muscle loss that happens with age

As the name implies, induced pluripotent stem cells can become any type of cell in our body, and scientists have evidence that when they prompt them to become muscle progenitor cells they can help restore the sometimes debilitating muscle loss that happens with age.

24 Mar 2021

Blood News and Research

Novel device can help treat type I diabetes mellitus

Study reveals molecular mechanisms involved in eliminating unwanted cells in the body

Key molecule determines the pathogenesis of lupus

Virus-cell interaction may explain the high infection rate of COVID-19 virus

New genetic evidence points to novel therapies for “silent” stroke

New technique can measure thousands of proteins in a few minutes

Fish oil provides health benefits based on the genetic makeup

New label-free immune profiling assay to assess rapidly changing host immune response

Researchers use mathematical modeling to explain CAR T-cell therapy dynamics

Scientists identify new biomarkers in the blood of patients with malignant melanoma

Study shows how a subset of T cells is generated in melanoma survivors affected by vitiligo

Study shows SARS-CoV-2 antibodies wane at different rates

Gender difference accounts for major psychiatric disorders

Stem cell therapy could help restore debilitating muscle loss that happens with age

Nutritional supplement may reduce the risk of strokes caused by a rare genetic disorder

Disease-driving B cells play a role in non-alcoholic fatty liver disease

Study into cellular filopodia could optimize cancer therapy and wound closure

New genetic engineering strategy largely reduces tau protein levels in Alzheimer’s animal model

Study maps structure, mechanism of membrane enzyme that has a role in chronic inflammation, cancer

Non-circulating memory T cells contribute to chronic transplant rejection

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics